Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.

Isabella Alviz Roberto C Cerrud-Rodriguez Juan Carlos DíazDaniel RodriguezSamiullah ArshadIsabella AlvizLuis CernaSaul RiosSanghamitra Mohanty Sanghamitra MohantyMario J GarciaLuigi Di Biase

Published in: Journal of cardiovascular electrophysiology (2019)

Continuation of OAC after CA of AF with CHA2 DS2 VASc ≥ 2 is associated with a significant decreased TE risk and a favorable net clinical benefit in spite of ICH being significantly increased in the ON-OAC group. Continued OAC offers no benefit with CHA2 DS2 VASC ≤ 1.

Keyphrases

atrial fibrillation
catheter ablation
left atrial
left atrial appendage
oral anticoagulants
direct oral anticoagulants
heart failure
percutaneous coronary intervention
coronary artery disease
left ventricular
venous thromboembolism
protein kinase
mitral valve